Nine pharmaceutical distribution enterprises work together to build a "cold chain"

2013-09-06 source: at the time when Shunfeng invested heavily in cold chain logistics, e-commerce giants such as store 1, tmall, Jingdong and Suning e-commerce launched a "cold war" caused by "fresh", pharmaceutical distribution enterprises were also excited and moved Recently, nine pharmaceutical distribution enterprises, including China Pharmaceutical Business Association United Nations pharmaceutical Holding Co., Ltd., kyushutong, China Resources Pharmaceutical Co., Ltd and Harbin Pharmaceutical Group, set up a temperature sensitive drug distribution safety laboratory (hereinafter referred to as the "laboratory"), and plan to formulate the pharmaceutical cold chain standard within three years According to the plan, the laboratory will enter the test phase from 2014, with a period of one year 2015 is the standard formulation and verification phase, and the results appraisal will be completed in the first half of 2016 In recent years, the State Food and Drug Administration and the Ministry of health and other relevant departments have been soliciting opinions for the revision of the new version of the "GSP" At the end of 2012, two national standards, cold chain logistics classification and basic requirements, and drug cold chain logistics operation specification, were successively issued The new version of GSP, which was officially implemented on June 1 this year, also emphasizes the management and promotion of cold chain of medicine Some analysts predict that by 2014, the market value of pharmaceutical cold chain will increase by 10% every year The original "scattered, small, disordered and weak" market of Chinese pharmaceutical cold chain will be reshuffled, and the challenge will bring more business opportunities and progress The reality is that at present, pharmaceutical logistics is not cold chain transportation It is understood that the investment in pharmaceutical cold chain is generally high Many pharmaceutical distribution enterprises are reluctant to use the high cost cold chain system in order to maximize profits As far as developed countries are concerned, pharmaceutical distribution enterprises need to ensure more than 25% of the gross profit rate to maintain healthy development At present, the gross profit rate of pharmaceutical distribution enterprises in China is generally less than 10%, and the low industry profits aggravate the disorder of competition "In this case, some large pharmaceutical companies prefer to build their own logistics centers at high cost rather than adopt the third-party logistics." The analysts said Reporters yesterday interviewed several listed pharmaceutical companies involved in the construction of the laboratory, including Jiuzhoutong, Shanghai pharmaceutical, China Resources pharmaceutical, Harbin Pharmaceutical Co., Ltd and other pharmaceutical circulation leaders have established their own pharmaceutical cold chain system Harbin Pharmaceutical Co., Ltd said that the company has a special pharmaceutical logistics company, while the group's bioengineering company also has its own cold chain logistics system to ensure the quality of drugs in the distribution process due to the demand of distribution of blood products, vaccines and other special drugs "The company develops its pharmaceutical distribution business with Shanghai Pharmaceutical Distribution holding as its core, and forms a nationwide distribution network through more than 40 subsidiaries and more than 30 logistics centers of the group," a person from Shanghai Pharmaceutical Securities Department told reporters Cold chain logistics is a very important part of the company's distribution settings for biological products " For this joint research on the cold chain strategy of Medicine jointly with China Pharmaceutical Business Association, the head of Jiuzhoutong pharmaceutical circulation department told reporters: "the company had its own logistics and distribution platform earlier, and built the corresponding cold chain system After the establishment of the laboratory, the company mainly undertakes the detection of cold chain logistics environment and equipment, which will not have a great impact on the company's logistics business in the short term We aim to establish more perfect and sound industry standards for the whole pharmaceutical cold chain industry "